We are live on ! Find out more
FRLN

Freeline Therapeutics Holdings plc American Depositary Shares
FRLN

Delisted

FRLN was delisted on the 16th of February, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

44.18% less ownership

Funds ownership: 44.18% → 0% (-44%)

100% less funds holding

Funds holding: 15 → 0 (-15)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $12.4M → $0 (-$12.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

Holders
–
Holders Change
-15
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SP
Syncona Portfolio
Guernsey
-$9.33M
2
UBS Group
UBS Group
Switzerland
-$633K
3
BOCH
Blue Owl Capital Holdings
New York
-$552K
4
PCM
PenderFund Capital Management
British Columbia, Canada
-$509K
5
JP Morgan Chase
JP Morgan Chase
New York
-$426K

FRLN Hedge Fund Activity: Q1 2024 in Review

0 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2024, worth a combined $0 — down 100% from $12.4M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of FRLN and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Syncona Portfolio, exiting entirely with an estimated $9.33M sold.

  • 0 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2024, down from 15 in Q4 2023.
  • Funds reported $0 of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2024 and 15 closed out, a net change of -15 holders.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2024 was Syncona Portfolio, an estimated $9.33M sold.

Based on aggregated 13F filings for Q1 2024.